Current calls
- 5 Oct
- 15 Nov
- 15 Nov
- 15 Nov
Learning about protein aggregates to solve the riddle of ALS
Each year some 200 Swedes are diagnosed with ALS, a neurodegenerative disorder that leads to serious symptoms. Palliative drugs are available, but there is no effective treatment. Many patients die within just a few years. Peter Andersen at Umeå University has studied ALS for thirty years, and found mechanisms that may make it possible to treat or even prevent it.
The ability of plants to react to damage
Wallenberg Academy Fellow Simon Stael has shown that a group of enzymes called proteases play a key role in damage response. He is now delving further into protease function.
Shedding new light on dark matter
No one has yet managed to show what dark matter is made of. At Stockholm University a new kind of sensor is being built to study hypothetical particles called axions. It may provide a solution to the mystery of dark matter.
Cancer driven by chromosome loss
Björn Reinius’ studies of X chromosomes have yielded new clues about what happens in cells when a chromosome copy is lost during cell division. His research team has discovered that, under certain conditions, the remaining copy may become hyperactive to compensate for the loss. He wants to learn more about how cancer cells react to chromosomal changes.
